Allianz Se Exact Sciences Corp Transaction History
Allianz Se
- $3.84 Trillion
- Q4 2024
A detailed history of Allianz Se transactions in Exact Sciences Corp stock. As of the latest transaction made, Allianz Se holds 109 shares of EXAS stock, worth $5,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109Holding current value
$5,487% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
665Shares Held
154MCall Options Held
2.3MPut Options Held
2.11M-
Vanguard Group Inc Valley Forge, PA17MShares$857 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$797 Million0.17% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$607 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$607 Million0.13% of portfolio
-
State Street Corp Boston, MA6.68MShares$336 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.91B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...